✦ LIBER ✦

Differences in estrogen receptor status, HER2, and p53 comparing metachronous bilateral breast carcinoma

✍ Scribed by Kaneyuki Matsuo; Takashi Fukutomi; Hitoshi Tsuda; Sadako Akashi-Tanaka; Chikako Shimizu; Tadashi Hasegawa

Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 75 KB
Volume: 77
Category: Article
ISSN: 0022-4790
DOI: 10.1002/jso.1062

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Estrogen receptor status in inflammatory

Estrogen receptor status in inflammatory breast carcinoma

✍ Harold A. Harvey; Allan Lipton; Bellarmine V. Lawrence; Deborah S. White; Samuel 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB

Association of hormone replacement thera

Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma

✍ Wendy Y. Chen; Susan E. Hankinson; Stuart J. Schnitt; Bernard A. Rosner; Michell 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 1 views

## Abstract ## BACKGROUND Observational studies and randomized trials have demonstrated that hormone replacement therapy (HRT) increases the recipient's risk of developing breast carcinoma. Because it is known that some breast malignancies are hormonally responsive and that others are not, it has

STAT3 ser727 phosphorylation and its ass

STAT3 ser727 phosphorylation and its association with negative estrogen receptor status in breast infiltrating ductal carcinoma

✍ Yao-Tsung Yeh; Fu Ou-Yang; I-Fen Chen; Sheau-Fang Yang; Yuan-Yung Wang; Hung-Yi 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 436 KB

## Abstract Although it is known that STAT3 transcriptional activity is modulated by phosphorylation at serine residue 727, the role of STAT3 serine phosphorylation in breast cancer remains mostly unexplored. In this study, we examined the expression patterns of serine residue 727‐phosphorylated ST

Correlation between p53, c-erbB-2, and t

Correlation between p53, c-erbB-2, and topoisomerase II? expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications

✍ Rudolph, Pierre; Olsson, H�kan; Bonatz, Gabriele; Ratjen, Virgo; Bolte, Hendrik; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 402 KB 👁 2 views

Various new prognostic indicators have been identified for mammary carcinomas, but the issue of their significance remains unsettled. The prognostic impact of p53, c-erbB-2, and topoisomerase II alpha expression was investigated in relation to standard prognostic factors for carcinomas of the breast

Influence of BRCA1 mutations on nuclear

Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women

✍ Stephen E. Karp; Patricia N. Tonin; Louis R. Bégin; John J. Martinez; Jian Chun 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 2 views

## RESULTS. In the 149 cases, the authors found 17 BRCA1 mutations (11.4%; 95%

Evaluation of new monoclonal antibodies

Evaluation of new monoclonal antibodies in detection of estrogen receptor, progesterone receptor, and Her2 protein expression in breast carcinoma cell block sections using conventional microscopy and quantitative image analysis

✍ K. Z. Hanley; M. T. Siddiqui; D. Lawson; C. Cohen; A. Nassar 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 372 KB 👁 1 views

## Abstract Accurate assessment of estrogen receptor (ER), progesterone receptor (PR), and Her2 status of breast carcinomas is critical for predicting response to systemic therapies. Recently, developed rabbit monoclonal antibodies (RMab) are reported to have higher sensitivity than murine monoclon